Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.
Journal: American journal of hematology
Published: October 29, 2024
Patient survey in immune thrombocytopenia (ITP): Identifying unmet needs related to treatment and disease control in patients living in the United States.
Journal: British journal of haematology
Published: October 02, 2024
Healthcare provider's perceptions of bleeding in patients with acute leukaemia undergoing induction chemotherapy: A qualitative study.
Journal: Transfusion medicine (Oxford, England)
Published: January 09, 2024
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia.
Journal: Blood advances
Published: October 27, 2023
Fewer severe infections with tranexamic acid in patients with hematologic malignancies.
Journal: Research and practice in thrombosis and haemostasis
Published: September 01, 2023
Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study.
Journal: Therapeutic advances in hematology
Published: June 23, 2023
Myoglobin saturation as an intracellular indicator for transfusion need in oncology patients.
Journal: Transfusion medicine (Oxford, England)
Published: June 21, 2023
Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia.
Journal: Research and practice in thrombosis and haemostasis
Published: November 15, 2022
Last Updated: 09/26/2026